MARKET WIREYahoo Finance • 22h ago
Delcath Systems to Host Third Quarter 2026 Earnings CallYahoo Finance report covering Delcath Systems Inc. (DCTH) market action, institutional positioning, and fundamental catalysts.
Why DCTH Stock advanced +1.78% Today — RQD Quant Desk Flash
$14.29 +1.78% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $14.31
Delcath Systems Inc. (DCTH) carries a Roarable Rating of C- (Hold) with 59/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
ROARABLE C- • HOLD / WATCH
Cap $487.2M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on DCTH Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is DCTH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Delcath Systems Inc. (NASDAQ: DCTH) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 59/100 at a spot price of $14.29 (+1.78% 1D, market cap $487.2M). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 7/20, SEC Balance-Sheet Forensics 18/20, FRED Macro Regime Fit 9/20, and Executive Insider Alignment 11/20. Across 1015 tracked Health Care issuers, DCTH ranks #171 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does DCTH compare to RCEL and SENS in the Health Care sector?
▼
Within the Health Care sector (Medical/Dental Instruments), DCTH carries a Roarable C- (59/100 RQD), trailing P/E of N/A, gross margin of 86.2%, and ROIC of 0.8%. By comparison, RCEL (Avita Medical Inc.) holds a D grade (46/100 RQD, P/E N/A, ROIC -35.0%, cap $484.0M) and SENS (Senseonics Holdings Inc.) posts a D- grade (40/100 RQD, P/E N/A, ROIC -35.0%, cap $502.8M). Among the 5-stock peer group, DCTH leads on earnings multiple (N/A) while DCTH leads on capital efficiency (0.8% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for DCTH?
▼
Per DCTH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000872912), Delcath Systems Inc. generated $85.2M in revenue (+129.1% YoY), $2.7M in net income, and $21.0M in free cash flow against $123.6M in total assets and $0 in total debt. Key quantitative strengths: Clean SEC annual filing review with no major hidden accounting time-bombs. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $14.31 (+0.13%)🧬 Cannibal Buyback (-0.96% YoY Shares)⚙️ Cash Engine: 14/20 (B-) • 24.6% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 59/100 (C-) historically posted market-perform odds over rolling 90-day windows (+0.2% avg 90D alpha vs SPY • 53.1% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →RQD QUANT TACHOMETERHOLD / WATCH • C-
2-of-3 JEV AI Jury Bullish
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D+ · Rk C+
Each axis scored 0–20
12M PRICE TARGET CONE+0.4% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for DCTH)Realized 20D OHLCV Swing Band: ±7.7%
Deterministic 5-Pillar Attribution (59/100 Composite)
🔍 WHY DCTH SCORES 59/100 (C-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (31% of score)
Altman Z-Score 20.33 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9
▲ #2 Bullish Driver: Cash Engine Quality+14/20 pts (24% of score)
SEC XBRL FY 2025 (10-K): 24.6% FCF Margin ($21.0M FCF) & 86.2% Gross Margin
▼ #1 Drag / Risk Factor: Whale & Options Positioning7/20 pts (-13 pt drag)
Put hedging (50% put share) caps near-term gamma upside (-13 pts vs max)
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade B-$15.32-3.7% Next Q
67
Q2 (-2Q)Grade C+$14.76-0.1% Next Q
64
Q3 (-1Q)Grade C+$14.75-3.1% Next Q
62
CurrentGrade C-$14.29+0.2% Hist 90D α
59
Trajectory: B- (67) → C- (59)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the DCTH Bull Thesis Could Fail
Even with a 59/100 (C-) score, DCTH faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Sensitive to high interest rates and tighter Federal Reserve market liquidity.
⚠️ Forensic Kill-Switch #2
Dilution & Margin Drag: Cannibal Buyback (-0.96% YoY Shares) — any gross margin slip below 83.7% triggers an automatic RQD downgrade.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($15.56) or 200D SMA ($12.38) invalidates the momentum regime and cuts Target Base ($14.35) toward Bear Floor ($11.19).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $DCTH• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “DCTH Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why DCTH Stock advanced +1.78% Today — RQD Quant Desk Flash
Delcath Systems Inc. (DCTH) advanced +1.78% to $14.29, trading at 66% of its 52-week range ($8.12 – $17.42). Solid 86.2% gross margin (1% return on capital), mixed timing at current multiples—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 66% of its 52-week range ($8.12 – $17.42) with RSI-14 at 40 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±7.7% around $14.29 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable C- (Hold) backed by 86.2% gross margin and $21.0M annual free cash flow.
Live DCTH Headlines & Catalysts
MARKET WIREBenzinga • 1d ago
Delcath Systems Q2 2026 Earnings Call TranscriptBenzinga report covering Delcath Systems Inc. (DCTH) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStocktwits • 1d ago
These Two Stocks Hit Fresh 52-Week Highs Today – DCTH Clocks Best Day In Nearly 15 MonthsStocktwits report covering Delcath Systems Inc. (DCTH) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStock Titan • 1d ago
A live webcast of the UBS conference will be available on Delcath's investor site, with an archive too.Stock Titan report covering Delcath Systems Inc. (DCTH) market action, institutional positioning, and fundamental catalysts.
RISK WATCHStock Traders Daily • 1d ago
How (DCTH) Movements Inform Risk Allocation ModelsStock Traders Daily report covering Delcath Systems Inc. (DCTH) market action, institutional positioning, and fundamental catalysts.
MARKET WIREhttps://www.siam.in/ • 1d ago
Delcath Systems (DCTH) Slips 2.24% to $14.42 as Shares Drift Toward Lower Support - Bollinger Walkhttps://www.siam.in/ report covering Delcath Systems Inc. (DCTH) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStock Titan • 1d ago
BlackRock reports a passive stake above 5% in Delcath Systems (DCTH).Stock Titan report covering Delcath Systems Inc. (DCTH) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStock Traders Daily • 1d ago
(DCTH) Volatility Zones as Tactical TriggersStock Traders Daily report covering Delcath Systems Inc. (DCTH) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo • 7d ago
Delcath Systems to Participate in Upcoming Investor ConferencesQUEENSBURY, N.Y., October 27, 2026--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that management will b
RISK WATCHYahoo • 14d ago
Delcath Systems Highlights Clinical Program Presentations at ESMO Congress 2026 and Independent Data on Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal MelanomaQUEENSBURY, N.Y., October 19, 2026--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced presentations related
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk
Scheduled RQD Strong Buys & Whale Accumulation Briefing (DCTH Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
DCTH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +29.67%🛡️ HOLDING TREND SUPPORT
2026-11-03O $14.64H $14.64L $14.04C $14.29VOL 427.4K
RES: $15.16SUP: $13.98SMA50: $15.56SMA200: $12.38
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
DCTH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth
vs. +129.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger
No active Ellis Vennor swing setup published on DCTH today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for DCTH. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for DCTH today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (DCTH)
Health Care Rank #171 of 1015
⚔️ RCEL vs DCTH Full Matrix →
1. Head-to-Head Health Care Peer Comparison (DCTH vs. RCEL, SENS, SSII, ANGO)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1015 tracked Health Care securities in the Roarable RQD universe, Delcath Systems Inc. (DCTH) ranks #171 by composite RQD confidence (59/100, grade C-) and #447 by equity capitalization ($487.2M). Within this direct 5-issuer industry benchmark cohort, DCTH leads on earnings valuation at N/A trailing P/E, while DCTH leads on capital efficiency and profitability with 0.8% ROIC and 86.2% gross margin. DCTH currently leads its immediate peer cohort in composite quantitative strength at 59/100 (C-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| DCTH
ACTIVE
Delcath Systems Inc. | C- | 59/100 | — | 86.2% | 0.8% | +1.78% | $487.2M | Benchmark Subject |
| RCEL Avita Medical Inc. | D | 46/100 | — | 82.1% | -35.0% | -1.53% | $484.0M | /rcel-vs-dcth → |
| SENS Senseonics Holdings Inc. | D- | 40/100 | — | 44.7% | -35.0% | -5.57% | $502.8M | /sens-vs-dcth → |
| SSII SS Innovations International Inc. | E | 30/100 | — | 46.0% | -18.5% | -1.70% | $471.1M | /ssii-vs-dcth → |
| ANGO AngioDynamics Inc. | D- | 36/100 | — | 54.6% | -23.4% | -1.92% | $504.2M | /ango-vs-dcth → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000872912 ↗In its most recent audited fiscal period (FY2025, filed 2025-12-31), Delcath Systems Inc. (DCTH) reported GAAP revenue of $85.2M (+129.1% vs. FY2024 revenue of $37.2M , and +4027.4% cumulative change since FY2023) , GAAP net income of $2.7M, operating cash flow of $22.5M, and free cash flow of $21.0M (+209.0% YoY). On the balance sheet, DCTH closed FY2025 with $123.6M in total assets against $0 in total debt (Altman Z-Score: 20.33, Piotroski F-Score: 8/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $85.2M | $2.7M | $22.5M | $21.0M | $123.6M | — |
| FY2024 (FY) | 2024-12-31 | $37.2M | -$26.4M | -$18.7M | -$19.2M | $76.6M | — |
| FY2023 (FY) | 2023-12-31 | $2.1M | -$47.7M | -$31.3M | -$31.3M | — | — |
3. DCTH Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs DCTH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Delcath Systems Inc. (NASDAQ: DCTH) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 59/100 at a spot price of $14.29 (+1.78% 1D, market cap $487.2M). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 7/20, SEC Balance-Sheet Forensics 18/20, FRED Macro Regime Fit 9/20, and Executive Insider Alignment 11/20. Across 1015 tracked Health Care issuers, DCTH ranks #171 in composite RQD confidence.
How does DCTH compare to RCEL and SENS in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), DCTH carries a Roarable C- (59/100 RQD), trailing P/E of N/A, gross margin of 86.2%, and ROIC of 0.8%. By comparison, RCEL (Avita Medical Inc.) holds a D grade (46/100 RQD, P/E N/A, ROIC -35.0%, cap $484.0M) and SENS (Senseonics Holdings Inc.) posts a D- grade (40/100 RQD, P/E N/A, ROIC -35.0%, cap $502.8M). Among the 5-stock peer group, DCTH leads on earnings multiple (N/A) while DCTH leads on capital efficiency (0.8% ROIC).
What are the biggest fundamental strengths and SEC risk factors for DCTH?
Per DCTH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000872912), Delcath Systems Inc. generated $85.2M in revenue (+129.1% YoY), $2.7M in net income, and $21.0M in free cash flow against $123.6M in total assets and $0 in total debt. Key quantitative strengths: Clean SEC annual filing review with no major hidden accounting time-bombs. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Institutional options positioning shows a 50% call / 50% put premium split.
Where is DCTH trading relative to its 50-day, 200-day, and 52-week technical levels?
DCTH last traded at $14.29 (+1.78% on volume of 364,906 shares), positioning the stock -8.16% below its 50-day simple moving average ($15.56) and +15.43% above its 200-day simple moving average ($12.38). Across its 52-week range of $8.12 to $17.42, DCTH sits at the 66.3% percentile with a 14-day RSI of 40.0 (NEUTRAL RANGE) and an implied next-earnings move of ±7.7% ($13.19 to $15.39).
ROARABLE RATING BRIEF • RQD 59/100 (C-)
✓ SEC XBRL & RQD VERIFIED
DCTH — Delcath Systems Inc.: What the Facts Mean to a Prospective Investor
Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31
1. Roarable Rating Brief: What This Means to a Prospective Investor
Delcath Systems Inc. (DCTH) earns a live Roarable RQD composite score of 59/100, corresponding to a C- letter grade (Roarable Hold) at a spot price of $14.29 (+1.78% 1D, market capitalization $487.2M).
- Fundamental Cash Engine (14/20): Anchored by return on invested capital (ROIC) of 0.8%, gross margin of 86.2%, operating margin of 0.8%, and free cash flow yield of 4.13%.
- Whale 13F & Options Flow (7/20) + Insider Conviction (11/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (9/20) + Forensic Balance Sheet (18/20): Incorporates a 1.00x equity beta, Altman Z-Score of 20.33, Piotroski F-Score of 8/9, and Debt/Equity of N/A.
2. Business Model, Unit Margins & SEC Financial Trajectory
Delcath Systems Inc. (DCTH) is a NASDAQ-listed issuer in the Health Care sector, within the Medical/Dental Instruments industry. The profile identifies the company as operating in this sector and industry with a market capitalization of $0.5B. Reported revenue grew from $2.1M in FY 2023 to $37.2M in FY 2024 and $85.2M in FY 2025.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Delcath Systems Inc. (DCTH) reported $85.2M in annual revenue (up from $37.2M in FY2024, +129.1% YoY) and $2.7M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($2.1M revenue, -$47.7M net income) through FY2025, DCTH scaled operating cash flow to $22.5M and free cash flow to $21.0M, backed by $123.6M in total assets against $0 in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (C- • RQD 59/100): Clean SEC annual filing review with no major hidden accounting time-bombs. Free cash flow yield of 4.13% and institutional whale pillar of 7/20. With Fundamental Cash Engine at 14/20 and Institutional Whale Flow at 7/20, sustained execution supports upside toward the upper end of the $8.12 – $17.42 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Investors must weigh current valuation against 0.8% operating margins and a 1.00x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
— The Butterfly Supply-Chain Graph lists no upstream or downstream links and no sector correlations. Investors should note that the dossier therefore cannot map supplier, customer, or competitor dependencies from the provided sources.
- Key Question #1: Can DCTH sustain or expand its 0.8% operating margin and 0.8% ROIC against Medical/Dental Instruments peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $85.2M and free cash flow of $21.0M, how will capital allocation balance growth reinvestment against $0 in total debt?
- Key Question #3: How sensitive is DCTH's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?
DCTH Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Delcath Systems Inc. (DCTH) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Yahoo Finance • 22h ago
Delcath Systems to Host Third Quarter 2026 Earnings Call Yahoo Finance report covering Delcath Systems Inc. (DCTH) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Benzinga • 1d ago
Delcath Systems Q2 2026 Earnings Call Transcript Benzinga report covering Delcath Systems Inc. (DCTH) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stocktwits • 1d ago
These Two Stocks Hit Fresh 52-Week Highs Today – DCTH Clocks Best Day In Nearly 15 Months Stocktwits report covering Delcath Systems Inc. (DCTH) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Titan • 1d ago
A live webcast of the UBS conference will be available on Delcath's investor site, with an archive too. Stock Titan report covering Delcath Systems Inc. (DCTH) market action, institutional positioning, and fundamental catalysts.
🔴 RISK WATCH Stock Traders Daily • 1d ago
How (DCTH) Movements Inform Risk Allocation Models Stock Traders Daily report covering Delcath Systems Inc. (DCTH) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE https://www.siam.in/ • 1d ago
Delcath Systems (DCTH) Slips 2.24% to $14.42 as Shares Drift Toward Lower Support - Bollinger Walk https://www.siam.in/ report covering Delcath Systems Inc. (DCTH) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Titan • 1d ago
BlackRock reports a passive stake above 5% in Delcath Systems (DCTH). Stock Titan report covering Delcath Systems Inc. (DCTH) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Traders Daily • 1d ago
(DCTH) Volatility Zones as Tactical Triggers Stock Traders Daily report covering Delcath Systems Inc. (DCTH) market action, institutional positioning, and fundamental catalysts.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
DCTH Bull vs. Bear Conversation Board — What's Your Call at $14.29?
🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON DCTH 🐻 33% BEARISH CONVICTION
QU QuantViper RQD DEBATE OPENER • Systematic Momentum Desk 🐂 BULLISH
🎯 Target: $17.41 (+24.0%)
📌 Pinned Debate Revenue scaled from $2.1M in FY 2023 to $85.2M in FY 2025 with FY 2025 FCF of $21.0M, and the forensic balance sheet scores 18 of 20.
Here is why I am bullish on DCTH here at $14.04: Revenue scaled from $2.1M in FY 2023 to $85.2M in FY 2025 with FY 2025 FCF of $21.0M, and the forensic balance sheet scores 18 of 20.. Compare DCTH's 0.8% operating margin and 0.8% ROIC against the rest of Medical/Dental Instruments. As long as cash conversion holds up, dips toward $13.34 are getting bought.
CapAlloc_Nerd 🐂 BULL
@QuantViper Agree on the RQD 59/100 quality, though with 1.0 beta I'm scaling in with half-size at $14.04 and keeping dry powder in case we test $13.06.
FO ForensicBear RQD DEBATE OPENER • 10-K Footnote Auditor 🐻 BEARISH
🎯 Target: $10.67 (-24.0%)
Spot @ $14.04 ROIC is only 0.8% and operating margin is 0.8%, with macro regime fit scoring 9 of 20 and no earnings multiples available to justify va
ROIC is only 0.8% and operating margin is 0.8%, with macro regime fit scoring 9 of 20 and no earnings multiples available to justify valuation.. Look at the math on DCTH: paying current EV/EBITDA multiples for 0.8% ROIC and 0.8% operating margins leaves zero margin of safety if Medical/Dental Instruments demand softens. I'd wait for a retest of $12.36 before getting long.